Bumetanide - NDC Database (Page 5)
23155-902 Jun 28, 2024
Bumetanide 2 mg Oral Tablet by Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.
Bumetanide 2 mg Oral Tablet by Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.
25021-321 Jun 01, 2024
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection, Solution by Sagent Pharmaceuticals
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection, Solution by Sagent Pharmaceuticals
31722-368 Feb 27, 2025
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Camber Pharmaceuticals, Inc.
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Camber Pharmaceuticals, Inc.
31722-369 Feb 27, 2025
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Camber Pharmaceuticals, Inc.
Bumetanide .25 mg/ml Intramuscular; Intravenous Injection by Camber Pharmaceuticals, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.